Grand Rounds Presentations
Methadone Patient Access to Collaborative Treatment (MPACT)
Beth Meyerson, MDiv, PhD | February 4, 2025 : Methadone Patient Access to Collaborative Treatment (MPACT) is an experimental, multimodal intervention for methadone clinic staff and funded by NIDA. This presentation will provide a brief overview of MPACT, discuss the planned hybrid trial (late fall 2025), the village that collaboratively developed MPACT and the importance…
Read MoreThe Buprenorphine Prescribing Support Program for Rural Primary Care
Berkeley Franz, PhD | January 28, 2025: Buprenorphine is a critical tool to prevent overdose and infectious disease transmission in people with opioid use disorder, but it is difficult to access in rural areas. A promising solution is to engage rural primary care professionals. But the willingness of primary care professionals to prescribe this medication presents…
Read MoreEstablishing Evidence Criteria to Evaluate and Identify Best Practice Implementation Strategies in HIV
Ginger McKay, PhD | January 21, 2025 : Given the progress of implementation research to address the HIV epidemic in the US, criteria specifically for evaluating the quality of implementation research and strategy effectiveness are needed to recommend strategies likely to have impact for practitioners. We will describe the development and application of the Best…
Read MoreRevisiting Concepts of Evidence in Implementation Science
Ross Brownson, PhD | January 14, 2025 : Evidence, in multiple forms, is a foundation of implementation research. For public health and clinical practice, evidence includes: Type 1 evidence on etiology and burden; Type 2 evidence on effectiveness of interventions; and Type 3: evidence on dissemination and implementation within context. Because current concepts of evidence…
Read MoreTransforming Health Systems to Address Addiction
Melissa Weimer, DO, MCR, FASAM | January 7, 2025: The talk will discuss the need to change health systems to address addiction and implementation strategies that promote change.
Read MoreCosting and Payment Tools in Addiction Research to Support Effective Dissemination of Economic Evidence
Kathryn McCollister, PhD | December 3, 2024 : Recent studies of the costs and economic impact of interventions for substance use disorder (SUD) have led to the development of costing tools and reimbursement calculators that support cost-effectiveness and cost-offset analyses and provide payers and other stakeholders with tailored products to assess budget impact and financial…
Read MoreUnderstanding the Impact of Discrimination on Substance Use Among Black Justice-Involved Youth: A NIDA K23 Study
Brittany Bryant, DSW, LCSW-CP/S | November 19, 202 : Substance use among Black justice-involved youth is a critical public health issue, often exacerbated by experiences of discrimination and systemic racism. This NIDA K23 study aims to investigate the complex relationship between discrimination and substance use within this vulnerable population. Through qualitative interviews, the study will…
Read MoreIntegration of a 1-session pain relief skills intervention across patient populations and practice settings
Beth Darnall, PhD | October 22, 2024 : While national best practices guidelines call for a biopsychosocial approach to treating acute and chronic pain, few evidence-based options are broadly accessible to the people who need them. Poor access to effective non-pharmacologic pain treatment contributes to substance use, pain care disparities and human suffering. Brief, effective,…
Read MoreTackling the Uptake of MOUD for Individuals Incarcerated in Jail
Todd Molfenter, PhD, Faye Taxman, PhD | October 8, 2024 : In an experiment that explored which implementation strategy—coaching using the NIATx goal process and ECHO, which prepares clinicians to increase the use of MOUD—affects the uptake and penetration of MOUD in jail settings. The presentation will: 1)identify techniques to correct misinformation; 2) discuss the impact…
Read MoreBetter, Faster, Cheaper, and Scaled: Opioid Use Disorder Treatment in the Fentanyl Era
Stephen Martin, MD, EdM, Stephanie Strong, CEO, Founder | September 24, 2024 : Treating opioid use disorder may be described as a “strike while the iron’s hot” scenario. Treatment must occur before doubts, withdrawal, or challenging life circumstances overwhelm someone who is interested, closing the window of opportunity. Despite nationwide efforts to expand access to…
Read More